ID   RN146_RAT               Reviewed;         352 AA.
AC   Q5XIK5;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   02-OCT-2024, entry version 122.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF146;
DE            EC=2.3.2.27;
DE   AltName: Full=Iduna;
DE   AltName: Full=RING finger protein 146;
DE   AltName: Full=RING-type E3 ubiquitin transferase RNF146 {ECO:0000305};
GN   Name=Rnf146;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-288 AND SER-292, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that specifically binds poly-ADP-
CC       ribosylated (PARsylated) proteins and mediates their ubiquitination and
CC       subsequent degradation. May regulate many important biological
CC       processes, such as cell survival and DNA damage response. Acts as an
CC       activator of the Wnt signaling pathway by mediating the ubiquitination
CC       of PARsylated AXIN1 and AXIN2, 2 key components of the beta-catenin
CC       destruction complex. Acts in cooperation with tankyrase proteins (TNKS
CC       and TNKS2), which mediate PARsylation of target proteins AXIN1, AXIN2,
CC       BLZF1, CASC3, TNKS and TNKS2. Recognizes and binds tankyrase-dependent
CC       PARsylated proteins via its WWE domain and mediates their
CC       ubiquitination, leading to their degradation. Different ubiquitin
CC       linkage types have been observed: TNKS2 undergoes ubiquitination at
CC       'Lys-48' and 'Lys-63', while AXIN1 is only ubiquitinated at 'Lys-48'.
CC       May regulate TNKS and TNKS2 subcellular location, preventing
CC       aggregation at a centrosomal location. Neuroprotective protein (By
CC       similarity). Protects the brain against N-methyl-D-aspartate (NMDA)
CC       receptor-mediated glutamate excitotoxicity and ischemia, by interfering
CC       with PAR-induced cell death, called parthanatos (By similarity).
CC       Prevents nuclear translocation of AIFM1 in a PAR-binding dependent
CC       manner (By similarity). Does not affect PARP1 activation. Protects
CC       against cell death induced by DNA damaging agents, such as N-methyl-N-
CC       nitro-N-nitrosoguanidine (MNNG) and rescues cells from G1 arrest (By
CC       similarity). Promotes cell survival after gamma-irradiation.
CC       Facilitates DNA repair (By similarity). {ECO:0000250|UniProtKB:Q9CZW6,
CC       ECO:0000250|UniProtKB:Q9NTX7}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Can form homooligomers. Interacts with PARsylated AXIN1,
CC       AXIN2, BLZF1, CASC3, H1-2, IPO7, LIG3, NCL, PARP1, XRCC1, XRCC5 and
CC       XRCC6. Interacts with DDB1, DHX15, IQGAP1, LRPPRC, PARP2, PRKDC,
CC       RUVBL2, TNKS1 and TNKS2. Binding often leads to interactor
CC       ubiquitination, in the presence of the appropriate E1 and E2 enzymes,
CC       and proteasomal degradation (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250}. Nucleus
CC       {ECO:0000250}. Note=Translocates to the nucleus after DNA damage, such
CC       as laser-induced DNA breaks, and concentrates at DNA breaks. This
CC       translocation requires PARP1 activation and PAR-binding (By
CC       similarity). {ECO:0000250}.
CC   -!- DOMAIN: The WWE domain mediates non-covalent poly(ADP-ribose)-binding.
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated; autoubiquitinated. Autoubiquitination is enhanced
CC       upon poly(ADP-ribose)-binding (By similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC083675; AAH83675.1; -; mRNA.
DR   RefSeq; NP_001012060.2; NM_001012060.2.
DR   AlphaFoldDB; Q5XIK5; -.
DR   BMRB; Q5XIK5; -.
DR   SMR; Q5XIK5; -.
DR   BioGRID; 258888; 1.
DR   STRING; 10116.ENSRNOP00000015421; -.
DR   iPTMnet; Q5XIK5; -.
DR   PhosphoSitePlus; Q5XIK5; -.
DR   PaxDb; 10116-ENSRNOP00000015421; -.
DR   ABCD; Q5XIK5; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000110925.1; ENSRNOP00000094151.1; ENSRNOG00000011588.7.
DR   Ensembl; ENSRNOT00000119984.1; ENSRNOP00000081042.1; ENSRNOG00000011588.7.
DR   Ensembl; ENSRNOT00055004921; ENSRNOP00055003645; ENSRNOG00055003168.
DR   Ensembl; ENSRNOT00055004929; ENSRNOP00055003652; ENSRNOG00055003168.
DR   Ensembl; ENSRNOT00055004931; ENSRNOP00055003654; ENSRNOG00055003168.
DR   Ensembl; ENSRNOT00060041066; ENSRNOP00060033995; ENSRNOG00060023731.
DR   Ensembl; ENSRNOT00060041085; ENSRNOP00060034014; ENSRNOG00060023731.
DR   Ensembl; ENSRNOT00065032146; ENSRNOP00065025657; ENSRNOG00065019124.
DR   Ensembl; ENSRNOT00065032149; ENSRNOP00065025660; ENSRNOG00065019124.
DR   Ensembl; ENSRNOT00065032164; ENSRNOP00065025675; ENSRNOG00065019124.
DR   GeneID; 308051; -.
DR   KEGG; rno:308051; -.
DR   UCSC; RGD:1306482; rat.
DR   AGR; RGD:1306482; -.
DR   CTD; 81847; -.
DR   RGD; 1306482; Rnf146.
DR   eggNOG; KOG0824; Eukaryota.
DR   GeneTree; ENSGT00390000000358; -.
DR   HOGENOM; CLU_067425_0_0_1; -.
DR   InParanoid; Q5XIK5; -.
DR   OrthoDB; 2881299at2759; -.
DR   PhylomeDB; Q5XIK5; -.
DR   Reactome; R-RNO-201681; TCF dependent signaling in response to WNT.
DR   Reactome; R-RNO-4641257; Degradation of AXIN.
DR   Reactome; R-RNO-5689880; Ub-specific processing proteases.
DR   Reactome; R-RNO-8948751; Regulation of PTEN stability and activity.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:Q5XIK5; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0072572; F:poly-ADP-D-ribose binding; ISS:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:InterPro.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IMP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:1900408; P:negative regulation of cellular response to oxidative stress; IMP:RGD.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; ISS:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd16546; RING-HC_RNF146; 1.
DR   Gene3D; 3.30.720.50; -; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR044110; RING-HC_RNF146.
DR   InterPro; IPR033509; RNF146.
DR   InterPro; IPR018123; WWE-dom_subgr.
DR   InterPro; IPR004170; WWE_dom.
DR   InterPro; IPR037197; WWE_dom_sf.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR13417:SF2; E3 UBIQUITIN-PROTEIN LIGASE RNF146; 1.
DR   PANTHER; PTHR13417; UNCHARACTERIZED; 1.
DR   Pfam; PF02825; WWE; 1.
DR   Pfam; PF13920; zf-C3HC4_3; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00678; WWE; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   SUPFAM; SSF117839; WWE domain; 1.
DR   PROSITE; PS50918; WWE; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transferase; Ubl conjugation; Ubl conjugation pathway;
KW   Wnt signaling pathway; Zinc; Zinc-finger.
FT   CHAIN           1..352
FT                   /note="E3 ubiquitin-protein ligase RNF146"
FT                   /id="PRO_0000056110"
FT   DOMAIN          91..167
FT                   /note="WWE"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00248"
FT   ZN_FING         36..74
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          195..242
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          259..293
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          317..352
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        195..237
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        259..275
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         107
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         110
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         114
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         144
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         153
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         163
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         175
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         288
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         292
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        84
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NTX7"
FT   CROSSLNK        94
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NTX7"
FT   CROSSLNK        130
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NTX7"
FT   CROSSLNK        175
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NTX7"
SQ   SEQUENCE   352 AA;  38224 MW;  A0AE19B1F23560C1 CRC64;
     MAGCGEIDHS LNMLPTNKKA SETCSNTAPS LTVPECAICL QTCVHPVSLP CKHVFCYLCV
     KGASWLGKRC ALCRQEIPED FLDKPTLLSP EELKAASRGN GEYVWYYEGR NGWWQYDERT
     SRELEDAFSK GKKNTEMLIA GFLYVADLEN MVQYRRNEHG RRRKIKRDII DIPKKGVAGL
     RLDCDSNTVN LARESSADGA DSGSAHTGAS VQLPVPSSTR PLTSVDGQLT SPVTPSPDAG
     ASLEDSFAHL QLSGDSIAER SHRGEGEEDH ESPSSGRVPD TSTEETESDA SSDIEDAPVV
     VAQHSLTQQR LLVSSANQTV AERSDRPVAG GGTMSVNVRS RRPDGQCTVT EV
//
